Risk Based Quality Management Summit that will be held from April 25-26, 2023 at the Le Méridien, in Philadelphia. The summit will be focused on conferring the details of executing data flow process maps, data monitoring tools, audit trails, and quality tolerance limits.
RBQM is now being embraced to address the significant increase in research duration, cost, and complexity of clinical research. The newest version of the Good Clinical Practice (“GCP”) quality standard extends the RBM approach to every facet of study execution, implementing the principles to all parts of quality management needing effective centralized monitoring systems and processes.
The 3rd Annual RBQM Summit will provide real-world lessons from businesses on the leading edge of execution and promote RBQM. This two-day event will feature plenary keynotes from biopharma thought leaders, focused on explicit functions and issues within clin ops, as well as research enterprise and innovation, with interactive and informal breakout discussion groups and networking.
Featured Topics and Discussions:
- Nurture a culture of efficiency and ensure end-to-end quality, cost management, and reliability
- Improve monitoring to include remote data monitoring, site and central monitoring
- Refine skills for risk identification, response, and mitigation
- Ensure the efficiency of QTLs and KRIs
- Ways to respond to central monitoring outputs
A risk-based approach to clinical trials helps to decrease trial costs and complexity while maximizing the R&D budget. The best practices in RBQM influence decentralized trials and clinical study methodology, focusing on risk-based data review including central and site monitoring.
The 3rd Risk Based Quality Management Summit is designed to help you establish cross-functional risk-management teams to manage your clinical trials, decreasing risks and improving drug development. Attendees will get access to valuable information on relevant matters in the risk-based management and monitoring space. Attendees can make the most of this engagement opportunity featuring live sessions, downloadable resources, and Q&A sessions.
Register today and hear the experts share advanced approaches and best practices to optimize data quality and improve risk management and trial efficiency.
To learn more, please visit https://nnw.fm/qwT7G.
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 50+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
NetworkNewsWire is part of the InvestorBrandNetwork
